NCT00003459View on ClinicalTrials.gov

Antineoplaston Therapy in Treating Patients With Brain Stem Glioma

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 31, 1996

Primary Completion Date

September 30, 2007

Study Completion Date

September 30, 2007

Conditions
Brain Stem Gliomas
Interventions
DRUG

Antineoplaston therapy (Atengenal + Astugenal)

Patients with a brain stem glioma will receive Antineoplaston therapy (Atengenal + Astugenal)

Trial Locations (1)

77055-6330

Burzynski Clinic, Houston

Sponsors
All Listed Sponsors
lead

Burzynski Research Institute

OTHER